Who
Philip J. Gotwals
Director
Company insider
Files Form 4 as: Director, OmniAb; Director, Capricor Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 21 Jul 2023
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 21 Apr 2026filed 21 Apr 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —13,333 | filing |
| 21 Apr 2026filed 21 Apr 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —13,333 at $0.00 | filing |
| 21 Apr 2026filed 21 Apr 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —13,333 at $0.00 | filing |
| 21 Apr 2026filed 21 Apr 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —13,333 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 21 Apr 2025filed 21 Apr 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 21 Apr 2025filed 21 Apr 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,940 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,160 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.